Objectives. To evaluate the risk of serious infections (SIs) in patients with RA treated with
anti-TNF therapy with emphasis on the risk across different ages. Methods. Using data from the …

Low back pain in adolescents is perceived to be uncommon in the clinic setting. However,
previous studies have suggested that it may be an important and increasing problem in this …

Objective Patients with rheumatoid arthritis (RA) who experience treatment failure with one
anti–tumor necrosis factor (anti‐TNF) agent, due to either inefficacy or toxicity, are frequently …

Objective. To determine the onset of low back pain (LBP) in schoolchildren and to investigate
the role of mechanical and psychosocial factors as risk factors for its onset. Methods. A …

Background: Low back pain (LBP) in schoolchildren with no apparent clinical cause is known
to be a common problem, but considerably less is understood regarding the aetiology of …

Objective To evaluate the effect of different concomitant disease modifying antirheumatic
drugs (DMARDs) on the persistence with antitumour necrosis factor (anti-TNF) therapies in …

Background: Anti-tumour necrosis factor (TNF)α treatments improve outcome in severe
rheumatoid arthritis (RA) and are efficacious in psoriasis and psoriatic arthritis. However recent …

Introduction Anti-TNF therapies represent a breakthrough in the treatment of severe psoriatic
arthritis. However, little is known about long-term drug persistence with these treatments in …

Objective The British Society for Rheumatology Biologics Register (BSRBR) has collected
data on adverse events including pregnancies in patients with rheumatoid arthritis treated with …

Introduction Anti-tumour necrosis factor (TNF) therapy is a mainstay of treatment in rheumatoid
arthritis (RA). In 2001, BSRBR was established to evaluate the safety of these agents. …